D. E. Shaw & Co., Inc. Immunocore Holdings PLC Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$33.78 - $63.75 $4.07 Million - $7.69 Million	-120,579 Reduced 86.07%	19,515 $661,000
Q1 2024 May 15, 2024	BUY	$60.14 - $75.36 $3.33 Million - $4.18 Million	55,441 Added 65.49%	140,094 $9.11 Million
Q4 2023 Feb 14, 2024	SELL	$42.85 - $69.5 $2.3 Million - $3.74 Million	-53,750 Reduced 38.84%	84,653 $5.78 Million
Q3 2023 Nov 14, 2023	SELL	$49.5 - $66.6 $4.04 Million - $5.43 Million	-81,556 Reduced 37.08%	138,403 $7.18 Million
Q2 2023 Aug 14, 2023	SELL	$48.54 - $61.64 $4.59 Million - $5.82 Million	-94,480 Reduced 30.05%	219,959 $13.2 Million
Q1 2023 May 15, 2023	SELL	$46.12 - $65.71 $2.26 Million - $3.22 Million	-48,960 Reduced 13.47%	314,439 $15.5 Million
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $10.5 Million - $15 Million	230,897 Added 174.26%	363,399 $20.7 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $4.95 Million - $7.61 Million	132,502 New	132,502 $6.22 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.